{"schema_version":"secwatch.filing_event.v1","accession":"0000885978-23-000006","form_type":"8-K","ticker":"USPH","cik":"0000885978","company_name":"U S PHYSICAL THERAPY INC /NV","filed_at":"2023-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.399261+00:00","generated_at":"2026-06-18T23:08:30.252208+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"USPH Q4 2022 GAAP diluted EPS -$0.01; Adj EBITDA $17.9M; raises dividend 4.9% to $0.43","bullets":["Q4 total revenue $141.2M (+8.7% YoY); GAAP net income $2.6M vs $10.2M; diluted EPS loss $0.01 vs $0.73.","Adjusted EBITDA Q4 $17.9M, up 2.8% from $17.4M (excl. Relief Funds) in Q4 2021.","Board raises quarterly dividend 4.9% to $0.43 per share, effective immediately.","2023 guidance: Adjusted EBITDA expected $75M-$80M from existing operations.","Goodwill impairment charge of $9.1M in Q4 related to IIP Acquisition."],"urls":{"canonical":"https://secwatch.observer/filing/0000885978-23-000006","json":"https://secwatch.observer/filing/0000885978-23-000006.json","markdown":"https://secwatch.observer/filing/0000885978-23-000006.md","text":"https://secwatch.observer/filing/0000885978-23-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885978/000088597823000006/0000885978-23-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885978/000088597823000006/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T23:08:30.252208+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"34e1b11662813b1a2b8b55d9190b94c82820f38d","claim":"U S PHYSICAL THERAPY INC /NV updated its the three months and year ended December 31, 2022 guidance (raised).","evidence_excerpt":"On February 28, 2023, U.S. Physical Therapy, Inc. (\"USPH\" or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention (“IIP”) services, reported final results for the three months and year ended December 31, 2022 (“2022 Fourth Quarter” and “2022 Year”, respectively).","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/885978/000088597823000006/0000885978-23-000006-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months and year ended December 31, 2022"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}